Statin therapy is associated with higher long-term but not perioperative survival after abdominal aortic aneurysm repair

Journal of Vascular Surgery

Volumn 68, Issue 2, 2018, Pages 392-399

  O'Donnell, Thomas F X ^a,b   Deery, Sarah E ^a,b   Shean, Katie E ^a,c   Mittleman, Murray A ^a,d   Darling, Jeremy D ^a   Eslami, Mohammad H ^e   DeMartino, Randall R ^f   Schermerhorn, Marc L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTIC ANEURYSM; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ENDOVASCULAR ANEURYSM REPAIR; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH VOLUME HOSPITAL; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; LONG TERM SURVIVAL; LOW VOLUME HOSPITAL; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OPEN SURGERY; PATIENT COMPLIANCE; PREOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY ANALYSIS; SURGICAL MORTALITY; BLOOD VESSEL TRANSPLANTATION; DIAGNOSTIC IMAGING; ENDOVASCULAR SURGERY; FACTUAL DATABASE; KAPLAN MEIER METHOD; MORTALITY; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROTECTION; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; DATABASES, FACTUAL; ENDOVASCULAR PROCEDURES; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MYOCARDIAL INFARCTION; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85044253441     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2017.11.084     Document Type: Article

References (32)

1. Iannuzzi, J.C., Rickles, A.S., Kelly, K.N., Rusheen, A.E., Dolan, J.G., Noyes, K., et al. Perioperative pleiotropic statin effects in general surgery. Surgery 155 (2014), 398–407.
2. London, M.J., Schwartz, G.G., Hur, K., Henderson, W.G., Association of perioperative statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern Med 177 (2017), 231–242.
3. McNally, M.M., Agle, S.C., Parker, F.M., Bogey, W.M., Powell, C.S., Stoner, M.C., Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 51 (2010), 1390–1396.
4. Antoniou, G.A., Hajibandeh, S., Hajibandeh, S., Vallabhaneni, S.R., Brennan, J.A., Torella, F., Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg 61 (2015), 519–532.e1.
5. Westin, G.G., Armstrong, E.J., Bang, H., Yeo, K.K., Anderson, D., Dawson, D.L., et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol 63 (2014), 682–690.
6. Kuhn, E.W., Slottosch, I., Wahlers, T., Liakopoulos, O.J., Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev, 2015, CD008493.
7. Sanders, R.D., Nicholson, A., Lewis, S.R., Smith, A.F., Alderson, P., Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev, 2013, CD009971.
8. Galiñanes, E.L., Reynolds, S., Dombrovskiy, V.Y., Vogel, T.R., The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes. Vascular 23 (2015), 344–349.
9. de Bruin, J.L., Baas, A.F., Heymans, M.W., Buimer, M.G., Prinssen, M., Grobbee, D.E., et al. Statin therapy is associated with improved survival after endovascular and open aneurysm repair. J Vasc Surg 59 (2014), 39–44.e1.
10. Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., Barnason, S.A., Beckman, J.A., Bozkurt, B., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), 2215–2245.
11. Wemmelund, H., Høgh, A., Hundborg, H.H., Thomsen, R.W., Johnsen, S.P., Lindholt, J.S., Statin use and rupture of abdominal aortic aneurysm. Br J Surg 101 (2014), 966–975.
12. De Martino, R.R., Beck, A.W., Hoel, A.W., Hallett, J.W., Arya, S., Upchurch, G.R., et al. Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative. J Vasc Surg 63 (2016), 182–189.e2.
13. Stone, N.J., Robinson, J., Lichtenstein, A.H., Merz, C.N.B., Blum, C.B., Eckel, R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 129:Suppl 2 (2014), S1–S45.
14. De Martino, R.R., Hoel, A.W., Beck, A.W., Eldrup-Jorgensen, J., Hallett, J.W., Upchurch, G.R., et al. Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival. J Vasc Surg 61 (2015), 1010–1019.
15. Schermerhorn, M.L., Bensley, R.P., Giles, K.A., Hurks, R., OʼMalley, A.J., Cotterill, P., et al. Changes in abdominal aortic aneurysm rupture and short-term mortality, 1995-2008. Ann Surg 256 (2012), 651–658.
16. Giles, K.A., Pomposelli, F., Hamdan, A., Wyers, M., Jhaveri, A., Schermerhorn, M.L., Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg 49 (2009), 543–550 discussion 550-1.
17. Reimerink, J.J., van der Laan, M.J., Koelemay, M.J., Balm, R., Legemate, D.A., Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm. Br J Surg 100 (2013), 1405–1413.
18. Pearson, T.A., Blair, S.N., Daniels, S.R., Eckel, R.H., Fair, J.M., Fortmann, S.P., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002), 388–391.
19. Third report of the national cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106 (2002), 3143–3421.
20. Durieux, R., Van Damme, H., Labropoulos, N., Yazici, A., Legrand, V., Albert, A., et al. High prevalence of abdominal aortic aneurysm in patients with three-vessel coronary artery disease. Eur J Vasc Endovasc Surg 47 (2014), 273–278.
21. Hernesniemi, J.A., Vänni, V., Hakala, T., The prevalence of abdominal aortic aneurysm is consistently high among patients with coronary artery disease. J Vasc Surg 62 (2015), 232–240.e3.
22. Van Kuijk, J.P., Flu, W.J., Dunckelgrun, M., Bax, J.J., Poldermans, D., Coronary artery disease in patients with abdominal aortic aneurysm: a review article. J Cardiovasc Surg (torino) 50 (2009), 93–107.
23. Chaikof, E.L., Brewster, D.C., Dalman, R.L., Makaroun, M.S., Illig, K.A., Sicard, G.A., et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg 50 (2009), S2–49.
24. Brown, O.W., Hollier, L.H., Pairolero, P.C., Kazmier, F.J., McCready, R.A., Abdominal aortic aneurysm and coronary artery disease. Arch Surg 116 (1981), 1484–1488.
25. O'Donnell, T.F., Deery, S.E., Darling, J.D., Shean, K.E., Mittleman, M.A., Yee, G.N., et al. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia. J Vasc Surg 66 (2017), 572–578.
26. Baxter, B.T., Terrin, M.C., Dalman, R.L., Medical management of small abdominal aortic aneurysms. Circulation 117 (2008), 1883–1889.
27. Stein, L.H., Berger, J., Tranquilli, M., Elefteraides, J.A., Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol 112 (2013), 1240–1245.
28. Neilipovitz, D.T., Bryson, G.L., Taljaard, M., STAR VaS—short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Can J Anesth 59 (2012), 527–537.
29. Durazzo, A.E., Machado, F.S., Ikeoka, D.T., De Bernoche, C., Monachini, M.C., Puech-Leão, P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004), 967–975.
30. Ford, I., Murray, H., Packard, C.J., Shepherd, J., Macfarlane, P.W., Cobbe, S.M., et al. Long-term follow-up of the west of Scotland coronary prevention study. N Engl J Med 357 (2007), 1477–1486.
31. Ho, P.M., Magid, D.J., Shetterly, S.M., Olson, K.L., Maddox, T.M., Peterson, P.N., et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 155 (2008), 772–779.
32. Beck, A.W., Sedrakyan, A., Mao, J., Venermo, M., Faizer, R., Debus, S., et al. Variations in abdominal aortic aneurysm care: a report from the international consortium of vascular registries. Circulation 134 (2016), 1948–1958.